Evaluating competing adverse and beneficial outcomes using a mixture model
- 17 April 2008
- journal article
- research article
- Published by Wiley in Statistics in Medicine
- Vol. 27 (21) , 4313-4327
- https://doi.org/10.1002/sim.3293
Abstract
A competing risk framework occurs when individuals have the potential to experience only one of the several mutually exclusive outcomes. Standard survival methods often overestimate the cumulative incidence of events when competing events are censored. Mixture distributions have been previously applied to the competing risk framework to obtain inferences regarding the subdistribution of an event of interest. Often the competing event is treated as a nuisance, but it may be of interest to compare adverse events against the beneficial outcome when dealing with an intervention. In this paper, methods for using a mixture model to estimate an adverse–benefit ratio curve (ratio of the cumulative incidence curves for the two competing events) and the ratio of the subhazards for the two competing events are presented. A parametric approach is described with some remarks for extending the model to include uncertainty in the event type that occurred, left truncation in order to allow for time‐dependent analyses, and uncertainty in the timing of the event resulting in interval censoring. The methods are illustrated with data from an HIV clinical cohort examining whether individuals initiating effective antiretroviral therapy have a greater risk of antiretroviral discontinuation or switching compared with HIV RNA suppression. Copyright © 2008 John Wiley & Sons, Ltd.Keywords
This publication has 43 references indexed in Scilit:
- Class of Antiretroviral Drugs and the Risk of Myocardial InfarctionNew England Journal of Medicine, 2007
- Tutorial in biostatistics: competing risks and multi‐state modelsStatistics in Medicine, 2006
- Reasons for Discontinuation of First Highly Active Antiretroviral Therapy in a Cohort of Proteinase Inhibitor???Naive HIV-Infected PatientsJAIDS Journal of Acquired Immune Deficiency Syndromes, 2001
- Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patientsAIDS, 2000
- Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosisAIDS, 1999
- A Proportional Hazards Model for the Subdistribution of a Competing RiskJournal of the American Statistical Association, 1999
- On the Use of Cause-Specific Failure and Conditional Failure Probabilities: Examples from Clinical Oncology DataJournal of the American Statistical Association, 1993
- Kaplan—meier, marginal or conditional probability curves in summarizing competing risks failure time data?Statistics in Medicine, 1993
- A Class of $K$-Sample Tests for Comparing the Cumulative Incidence of a Competing RiskThe Annals of Statistics, 1988
- A Mixture Model for the Regression Analysis of Competing Risks DataJournal of the Royal Statistical Society Series C: Applied Statistics, 1985